Hospira, Inc. et al. v. Sylvia Matthews Burwell, et al., Case No. 14-cv-02662 (D. Md.), No. 14-1920 (4th Cir.) | Part of litigation team for intervenor Par Sterile Products LLC in case brought by Hospira in the District of Maryland against U.S. Food & Drug Administration to rescind approval for generic Precedex® (dexmedetomidine) products. Par obtained summary judgment allowing it to market its product and later prevailed on appeal to the Fourth Circuit, after which the case settled favorably

Posted on Sep 12, 2017 in